Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilanjan Saha

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
European Journal of Clinical Pharmacology|July 18, 2023
Impact of tofogliflozin on hepatic outcomes: a systematic reviewMani Pathak, Rizwana Parveen, Parvej Khan, et al.
Expert Opinion on Pharmacotherapy|May 28, 2024
Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trialsRizwana Parveen, Shadan Hussain, Sparsh Saini, et al.
Expert Opinion on Pharmacotherapy|April 2, 2025
Efficacy and safety of taletrectinib for treatment of ROS1 positive non-small cell lung cancer: A systematic reviewIrtiqa Khan, Atiya Sahar, Suhaiba Numra, et al.
Journal of Clinical Pharmacology|March 19, 2011
Comparative evaluation of US Food and Drug Administration and pharmacologically guided approaches to determine the maximum recommended starting dose for first-in-human clinical trials in adult healthy menMd Tarique Imam, S P Venkateshan, Monika Tandon, et al.
International Journal of Clinical Practice|September 22, 2021
Venous thromboembolism is linked to severity of disease in COVID-19 patients: A systematic literature review and exploratory meta-analysisRashmi Srivastava, Rizwana Parveen, Pinki Mishra, et al.
Journal of Clinical Pharmacology|November 19, 2013
Safety, tolerability and pharmacokinetic profile of single and multiple oral doses of arterolane (RBx11160) maleate in healthy subjectsNilanjan Saha, Joerg J Moehrle, Anita Zutshi, et al.
Minerva Endocrinology|June 4, 2021
Elevated urinary IL-36α and IL-18 levels are associated with diabetic nephropathy in patients with type 2 diabetes mellitusRohan Chakraborty, Rizwana Parveen, Prabhat Varshney, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 28, 2025
An observational study on multidrug resistance in pediatric patients with urinary tract infectionsGarzain Bint E Attar, Shaista Ahmed, Neetu Shree, et al.
ACS Omega|May 8, 2023
Deciphering the Precise Target for Saroglitazar Associated Antiangiogenic Effect: A Computational Synergistic ApproachSwarna Dabral, Imran Ahmd Khan, Tarun Pant, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|March 27, 2007
Validation and estimation of parameters for a general probabilistic model of the PCR processNilanjan Saha, Layne T Watson, Karen Kafadar, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
European Journal of Clinical Pharmacology|July 18, 2023
Impact of tofogliflozin on hepatic outcomes: a systematic reviewMani Pathak, Rizwana Parveen, Parvej Khan, et al.
Expert Opinion on Pharmacotherapy|May 28, 2024
Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trialsRizwana Parveen, Shadan Hussain, Sparsh Saini, et al.
Expert Opinion on Pharmacotherapy|April 2, 2025
Efficacy and safety of taletrectinib for treatment of ROS1 positive non-small cell lung cancer: A systematic reviewIrtiqa Khan, Atiya Sahar, Suhaiba Numra, et al.
Journal of Clinical Pharmacology|March 19, 2011
Comparative evaluation of US Food and Drug Administration and pharmacologically guided approaches to determine the maximum recommended starting dose for first-in-human clinical trials in adult healthy menMd Tarique Imam, S P Venkateshan, Monika Tandon, et al.
International Journal of Clinical Practice|September 22, 2021
Venous thromboembolism is linked to severity of disease in COVID-19 patients: A systematic literature review and exploratory meta-analysisRashmi Srivastava, Rizwana Parveen, Pinki Mishra, et al.
Journal of Clinical Pharmacology|November 19, 2013
Safety, tolerability and pharmacokinetic profile of single and multiple oral doses of arterolane (RBx11160) maleate in healthy subjectsNilanjan Saha, Joerg J Moehrle, Anita Zutshi, et al.
Minerva Endocrinology|June 4, 2021
Elevated urinary IL-36α and IL-18 levels are associated with diabetic nephropathy in patients with type 2 diabetes mellitusRohan Chakraborty, Rizwana Parveen, Prabhat Varshney, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 28, 2025
An observational study on multidrug resistance in pediatric patients with urinary tract infectionsGarzain Bint E Attar, Shaista Ahmed, Neetu Shree, et al.
ACS Omega|May 8, 2023
Deciphering the Precise Target for Saroglitazar Associated Antiangiogenic Effect: A Computational Synergistic ApproachSwarna Dabral, Imran Ahmd Khan, Tarun Pant, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|March 27, 2007
Validation and estimation of parameters for a general probabilistic model of the PCR processNilanjan Saha, Layne T Watson, Karen Kafadar, et al.
Pageof 3